Transcriptomics

Dataset Information

0

Matrisome gene expression in treatment-naïve and chemotherapy-treated primary tumor and metastatic tissues of high-grade serous ovarian carcinoma


ABSTRACT: The extracellular matrix (ECM) of tumors differ significantly from that in normal tissues. Biochemical cues from the tumor ECM critically affect intratumoral signaling contributing to tumor malignancy, growth and response to treatment. In this study, we characterized the expression of 1,027 genes encoding core extracellular matrix and associated proteins defined as the matrisome (Naba et al., 2016) in treatment-naïve and chemotherapy-treated high-grade serous ovarian carcinoma (HGSC) using longitudinal patient cohort consisting of 165 samples. The expression profiling was conducted by using 45 primary tumor samples, 93 metastatic omental-peritoneal-mesenteric tissue samples and 27 ascites-derived cancer cell samples from HGSC patients. By comparing the matrisome gene expression between the primary tumor and metastatic tissues pre- and post-chemotherapy, we identified the cancer cell surrounding fibro-inflammatory tumor-microenvironment to be markedly different in primary tumors compared to metastatic tissues and to change in response to chemotherapy, in terms of both the extent and type of the extracellular matrix proteins. Further study on these specific genes may aid finding potential therapeutic ECM gene targets to enhance HGSC patient outcome.

ORGANISM(S): Homo sapiens

PROVIDER: GSE173420 | GEO | 2021/04/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-03-24 | GSE186145 | GEO
2022-10-05 | PXD036736 | Pride
2020-05-27 | PXD014980 | Pride
2022-03-14 | PXD032002 | Pride
2021-09-01 | GSE173204 | GEO
2020-05-26 | PXD013350 | Pride
2017-08-25 | GSE86273 | GEO
2024-10-08 | GSE266577 | GEO
2024-01-24 | GSE234660 | GEO
2018-07-19 | MSV000082639 | MassIVE